Shionogi-Backed Apnimed Files for IPO to Fund Sleep Apnea Drug
2026-07-10 21:36:11
Apnimed Inc., backed by Shionogi, filed for a US initial public offering as it seeks funding while its oral drug to treat obstructive sleep apnea moves closer to commercialization, according to Bloomberg.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
地缘政治 | 古巴本周第二次全国停电
